Literature DB >> 20934460

Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules.

Ruth Harvey1, Carolyn Nicolson, Rachel E Johnson, Kate A Guilfoyle, Diane L Major, James S Robertson, Othmar G Engelhardt.   

Abstract

The candidate vaccine virus NIBRG-14 was derived by reverse genetics and comprises the haemagglutinin (HA) and neuraminidase (NA) genes derived from the clade 1 virus A/Viet Nam/1194/2004 on an A/Puerto Rico/8/34 (PR8) backbone. The HA gene was modified to remove the multibasic cleavage site motif associated with high pathogenicity. Reports from manufacturers, confirmed by data generated in this laboratory, have shown that this virus yields a low amount of HA antigen. We have generated a panel of new viruses using reverse genetics in which each virus consists of the PR8 backbone, the NA gene from A/Viet Nam/1194/2004 and a chimeric HA gene with sequences from both PR8 and A/Viet Nam/1194/2004. Here we show that a number of these viruses have improved HA antigen content and yield and are therefore better candidate vaccine viruses for use in production of H5N1 vaccine.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20934460     DOI: 10.1016/j.vaccine.2010.09.006

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.

Authors:  Nicholas C Wu; Jia Xie; Tianqing Zheng; Corwin M Nycholat; Geramie Grande; James C Paulson; Richard A Lerner; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2017-06-14       Impact factor: 21.023

2.  Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.

Authors:  Ruth Harvey; Kate A Guilfoyle; Sarah Roseby; James S Robertson; Othmar G Engelhardt
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates.

Authors:  Jianqiang Ye; Feng Wen; Yifei Xu; Nan Zhao; Liping Long; Hailiang Sun; Jialiang Yang; Jim Cooley; G Todd Pharr; Richard Webby; Xiu-Feng Wan
Journal:  Virology       Date:  2015-04-17       Impact factor: 3.616

4.  Permissible variation in the 3' non-coding region of the haemagglutinin genome segment of the H5N1 candidate influenza vaccine virus NIBRG-14 [corrected].

Authors:  Rachel E Johnson; Michelle Hamill; Ruth Harvey; Carolyn Nicolson; James S Robertson; Othmar G Engelhardt
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

5.  Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs.

Authors:  Adam Johnson; Li-Mei Chen; Emily Winne; Wanda Santana; Maureen G Metcalfe; Guaniri Mateu-Petit; Callie Ridenour; M Jaber Hossain; Julie Villanueva; Sherif R Zaki; Tracie L Williams; Nancy J Cox; John R Barr; Ruben O Donis
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

6.  Efficient generation of recombinant influenza A viruses employing a new approach to overcome the genetic instability of HA segments.

Authors:  Ahmed Mostafa; Pumaree Kanrai; Henning Petersen; Sherif Ibrahim; Silke Rautenschlein; Stephan Pleschka
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

7.  Development of high-yield influenza A virus vaccine viruses.

Authors:  Jihui Ping; Tiago J S Lopes; Chairul A Nidom; Elodie Ghedin; Catherine A Macken; Adam Fitch; Masaki Imai; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Nat Commun       Date:  2015-09-02       Impact factor: 14.919

8.  A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine.

Authors:  Ruth Harvey; Rachel E Johnson; Kirsty MacLellan-Gibson; James S Robertson; Othmar G Engelhardt
Journal:  Influenza Other Respir Viruses       Date:  2014-08-02       Impact factor: 4.380

9.  A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.

Authors:  Giuseppina Di Mario; Bruno Garulli; Ester Sciaraffia; Marzia Facchini; Isabella Donatelli; Maria R Castrucci
Journal:  Virol J       Date:  2016-03-31       Impact factor: 4.099

10.  Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses.

Authors:  Saira Hussain; Matthew L Turnbull; Helen M Wise; Brett W Jagger; Philippa M Beard; Kristina Kovacikova; Jeffery K Taubenberger; Lonneke Vervelde; Othmar G Engelhardt; Paul Digard
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.